Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2020 16:10 ET | Source: Vaxil Bio Ltd.

VAXIL Provides Update on USAMRIID and Oral Experiments

NESS-ZIONA, Israel, Dec. 29, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
December 22, 2020 07:50 ET | Source: Vaxil Bio Ltd.

Vaxil Retains Investor Engagement and Marketing Firm

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 22, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
December 10, 2020 07:50 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Close of Second and Final Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $264,100

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 10, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
December 03, 2020 07:55 ET | Source: Vaxil Bio Ltd.

Vaxil Provides Business Update on Corvax™ Experiments

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Dec. 03, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
November 24, 2020 07:00 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Close of First Tranche of Previously Announced Non-Brokered Private Placement for Gross Proceeds of $542,858

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
November 09, 2020 10:19 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Non-Brokered Private Placement

NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Nov. 09, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
October 26, 2020 11:57 ET | Source: Vaxil Bio Ltd.

Vaxil Enters Into a Cooperative Research and Development Agreement With U.S. Army Medical Research Institute of Infectious Diseases (“USAMRIID”)

NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Oct. 26, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
October 13, 2020 07:30 ET | Source: Vaxil Bio Ltd.

Vaxil Initiates Pre-Clinical Study in New Oncology Target

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
September 17, 2020 08:30 ET | Source: Vaxil Bio Ltd.

Vaxil Provides Update of Conversion of Previously Issued Convertible Debt and the Granting of Options

Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Sept. 17, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
September 08, 2020 08:40 ET | Source: Vaxil Bio Ltd.

Vaxil Announces Positive Results on CorVax™ in vivo Study

NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...